NovaBridge Biosciences Capital Expenditures (CapEx) Growth & History (NBP)

NovaBridge Biosciences's capital expenditures (capex) was $7,000 for fiscal 2025.

View full NovaBridge Biosciences company overview

NovaBridge Biosciences annual capital expenditures (capex) history

NovaBridge Biosciences annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$7,000−$41,000−85.42%
20242024-12-31$48,000−$116,000−70.73%
20232023-12-31$164,000−$1.9M−92.16%
20222022-12-31$2.1M−$2.6M−55.48%
20212021-12-31$4.7M$3.5M+282.80%
20202020-12-31$1.2M−$531,000−30.20%
20192019-12-31$1.8M

NovaBridge Biosciences capital expenditures (capex) trends

Over the last five fiscal years, NovaBridge Biosciences's capital expenditures (capex) decreased from $1.2M to $7,000, a change of −$1.2M. The latest reported quarter, Q3 2025, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review NovaBridge Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about NBP yet. Start the conversation.

Write the first post